Disposable Pipette Tips Market Size, Trends and Growth Analysis by 2027

The market for disposable pipette tips is anticipated to grow significantly, reaching an estimated US$ 166.57 million by 2028, up from US$ 88.51 million in 2021. This growth represents a compound annual growth rate (CAGR) of 9.5% from 2021 to 2028.

Several factors are contributing to the expansion of the disposable pipette tips market, particularly the surge in research activities within the biotechnology field and ongoing advancements in healthcare. However, the trend of reusing plastic pipette tips poses a challenge to market growth.

Recent technological innovations in genomics have brought about remarkable transformations in the healthcare landscape. The genomics sector is currently influenced by nine key trends: the rise of Next-Generation Sequencing (NGS), developments in single-cell biology, advancements in RNA biology, the emergence of molecular stethoscopes, genetic testing, genomic-based patient diagnostics, bioinformatics, extensive research initiatives, and clinical trials. These trends present significant commercial opportunities for in vitro diagnostic (IVD) companies. Over the past thirty years, genomics has surpassed expectations, driven by technological advancements that enable researchers to explore larger segments of the human genome.

Genomic technologies have not only revolutionized research but have also opened doors for clinical genomics, often referred to as molecular diagnostics. These technologies have enhanced testing capabilities across various domains, including infectious diseases, cancer, and inherited disorders, by allowing the measurement of new biomarkers. The improvements in analytical performance and the speed of advancements compared to traditional testing methods are noteworthy.

Key players in this field, such as Illumina, Qiagen, Thermo Fisher Scientific Inc., Agilent, and Roche, are at the forefront of innovation, continuously developing new products for genomics. The introduction of advanced technologies necessitates increased automation in laboratories to streamline processes and minimize manual labor, thereby enhancing operational efficiency. Consequently, the growth of genomic technologies in life sciences, medical diagnostics, and research is expected to be a significant trend, leading to a heightened demand for both basic and advanced pipetting techniques throughout the forecast period.

The disposable pipette tips market can be categorized by type into two segments: non-filtered pipette tips and filtered pipette tips. In 2021, the non-filtered pipette tips segment dominated the market, as these tips are essential tools in laboratories and are typically the most economical choice. They are available in bulk (e.g., in bags) and pre-racked for convenience. Non-filtered tips can be either pre-sterilized or non-sterilized and are compatible with both manual and automated pipettes. Major manufacturers, including Labcon, Corning Incorporated, and Tecan Trading AG, provide these types of tips. On the other hand, the filtered pipette tips segment is projected to experience a higher CAGR of 10.8% during the forecast period, as these tips offer greater convenience and cost-effectiveness. Companies such as Thermo Fisher Scientific, Sartorius AG, Gilson Incorporated, and Eppendorf are key suppliers of filtered pipette tips.

When examining applications, the disposable pipette tips market is divided into segments including hospitals, research institutions, and others. The research institutions segment held the largest market share in 2021 and is expected to achieve the highest CAGR during the forecast period.

Additionally, the market is segmented by product type into robotic pipette tips and non-robotic pipette tips. The robotic pipette tips segment was the largest in 2021 and is projected to maintain the highest growth rate in the coming years.

In preparing the report on the disposable pipette tips market, various reputable secondary sources were consulted, including the Center for Drug Evaluation and Research (CDER), National Healthcare Service (NHS), Centers for Disease Control and Prevention (CDC), Federal Statistics Office 2018, National Center for Biotechnology Information, European Federation of Pharmaceutical Industries and Associations, United Nations Office for the Coordination of Humanitarian Affairs (UNOCHA), World Bank Data, United Nations (UN), and World Health Organization (WHO).